TP53 and hepatocellular carcinoma: A recent study by Feng et al. suggests that ERS in HCC cells can induce CNYP2, thereby activating three response pathways of UPR, inhibiting the expression of tumor suppressor gene p53 and shortening the cell cycle, ultimately promoting the occurrence of HCC [106].